{"id":"W2894235280","doi":"10.1016/s1474-4422(18)30319-3","title":"Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial","year":2018,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Cardiovascular and Diving-Related Complications","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":true,"ca_institutions":"Impact; Western University; Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Janssen Pharmaceuticals; Janssen Research and Development; Covidien; Bayer Fund; Boston Scientific Corporation; Sanofi; GlaxoSmithKline; Daiichi-Sankyo; Boehringer Ingelheim; Amgen; National Heart, Lung, and Blood Institute; Pfizer; Bristol-Myers Squibb; Bayer","keywords":"Medicine; Rivaroxaban; Patent foramen ovale; Aspirin; Stroke (engine); Subgroup analysis; Internal medicine; Population; Randomized controlled trial; Cardiology; Surgery; Pediatrics; Meta-analysis; Warfarin; Atrial fibrillation; Migraine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006655205,0.002406883,0.009759906,0.001769206,0.0004462328,0.001916031,0.001124773,0.001762841,0.004019616],"category_scores_gemma":[0.01150065,0.0006504519,0.03705646,0.001737926,0.0004891658,0.001030153,0.0009715474,0.001573768,0.0003398701],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001169283,"about_ca_system_score_gemma":0.001300474,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003632076,"about_ca_topic_score_gemma":0.008541257,"domain_scores_codex":[0.9945822,0.002522836,0.00136637,0.0007278055,0.0005063369,0.0002944352],"domain_scores_gemma":[0.9965495,0.001941516,0.0007709462,0.0003415371,0.0002837116,0.0001127947],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.08213695,0.0001073725,0.009428238,0.06688406,0.8265316,0.0003156331,0.0001341383,0.001054191,0.001152443,0.0002298942,0.001390237,0.01063528],"study_design_scores_gemma":[0.03904501,0.001042932,0.01006894,0.002223665,0.9446991,0.0001506103,0.00005262069,0.0004719516,0.0003096922,0.0005717533,0.001320722,0.00004291979],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.2836232,0.69502,0.004086431,0.001120152,0.001608535,0.003367896,0.007836005,0.0002094877,0.00312835],"genre_scores_gemma":[0.9390208,0.04896226,0.001834246,0.001419937,0.0005968195,0.003285245,0.003582292,0.00006676139,0.001231516],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.009759906,"threshold_uncertainty_score":0.03519648,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.105807916589741,"score_gpt":0.3215762508997315,"score_spread":0.2157683343099904,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}